Valneva SE (VALN) Current Assets (2020 - 2026)

Valneva SE's (VALN) quarterly Current Assets came in at $235.8 million in Q1 2026, down 21.89% year-on-year from $301.9 million in Q1 2025, and down 8.96% quarter-over-quarter from $259.0 million in Q4 2025.

Valneva SE (VALN) Current Assets (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Current Assets across 7 years of filings, most recently posting $235.8 million for Q1 2026.

  • Current Assets for Q1 2026 came in at $235.8 million, down 21.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $235.8 million (down 21.89% YoY), and the FY2025 annual result was $259.0 million, down 18.93% from the prior year.
  • Current Assets came in at $235.8 million for Q1 2026 at Valneva SE, down from $259.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $611.7 million in Q1 2022 to a low of $235.8 million in Q1 2026.
  • The 5-year median for Current Assets is $332.7 million (2024), against an average of $364.3 million.
  • Across the five-year window, Current Assets plunged 35.35% in 2022 and increased 12.99% in 2024, its largest moves.
  • Valneva SE's Current Assets stood at $433.3 million in 2022, then sank by 34.73% to $282.8 million in 2023, then grew by 12.99% to $319.5 million in 2024, then decreased by 18.93% to $259.0 million in 2025, then retreated by 8.96% to $235.8 million in 2026.
  • The last three Current Assets figures came in at $235.8 million (Q1 2026), $259.0 million (Q4 2025), and $313.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 37.31 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 521.86 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 10.37 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.25 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 3.59 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 7.63 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 11.73 Bn
9 Abivax 94.26 Bn 94.26 Bn - 600.85 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 235.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 235.83 Mn
Dec 31, 2025 259.05 Mn
Sep 30, 2025 313.69 Mn
Jun 30, 2025 322.29 Mn
Mar 31, 2025 301.94 Mn
Dec 31, 2024 319.52 Mn
Sep 30, 2024 333.43 Mn
Jun 30, 2024 289.85 Mn
Mar 31, 2024 332.69 Mn
Dec 31, 2023 282.78 Mn
Sep 30, 2023 349.06 Mn
Jun 30, 2023 371.85 Mn
Mar 31, 2023 417.88 Mn
Dec 31, 2022 433.26 Mn
Sep 30, 2022 480.48 Mn
Jun 30, 2022 537.56 Mn
Mar 31, 2022 611.70 Mn
Dec 31, 2021 670.17 Mn
Dec 31, 2020 367.73 Mn